Northwest Biotherapeutics's total assets for Q3 2024 were $29.32M, an increase of 3.88% from the previous quarter. NWBO total liabilities were $93.56M for the fiscal quarter, a 8.83% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.